Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Overview of attention for article published in Diabetologia, August 2009

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 4 news stories from 3 outlets.

AT THE ANNUAL SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION PHILADELPHIA – Daily glargine use among patients with…

1. ElSayed NA, Aleppo G, Aroda VR, et al. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023.

Om P. Ganda, MD, Chair, Clinical Oversight Committee; Alissa Segal, PharmD, CDE, CDTC; Elizabeth Blair, MS, ANP-BC, CDE, CDTC…

European Medicines Agency. Byetta: EPAR - Summary for the public. 2009. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.